Quidel Corporation (QDEL) News

Quidel Corporation (QDEL): $112.32

2.26 (+2.05%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter QDEL News Items

QDEL News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

QDEL News Highlights

  • For QDEL, its 30 day story count is now at 84.
  • Over the past 22 days, the trend for QDEL's stories per day has been choppy and unclear. It has oscillated between 1 and 37.
  • OCDX, LAW and SNAP are the most mentioned tickers in articles about QDEL.

Latest QDEL News From Around the Web

Below are the latest news stories about Quidel Corp that investors may wish to consider to help them evaluate QDEL as an investment opportunity.

Hedge Funds Are Coming Back To Quidel Corporation (QDEL)

Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities

Insider Monkey | January 12, 2022

Philips' (PHG) Q4 Earnings Hit By Supply-Chain Issues, Recall

Philips (PHG) fourth-quarter and 2021 results suffer from supply-chain constraints and adverse impact of the Respironics recall.

Yahoo | January 12, 2022

Quidel (QDEL) Stock Sinks As Market Gains: What You Should Know

Quidel (QDEL) closed the most recent trading day at $127.71, moving -1.98% from the previous trading session.

Yahoo | January 11, 2022

Quidel Corporation (QDEL) Reports Solid Preliminary Q4 Revenues

Quidel's (QDEL) revenue growth in the fourth quarter is likely to have been boosted by continued robust sales of its SARS-related products.

Yahoo | January 11, 2022

GameStop, Sonos, Quidel Rise Premarket; Kohls Falls

By Peter Nurse

Yahoo | January 7, 2022

Stocks making the biggest moves after hours: GameStop, Quidel & T-Mobile

Check out the companies making headlines in after-hours trading.

CNBC | January 6, 2022

Quidel Announces Preliminary Revenue for Fourth Quarter 2021

SAN DIEGO, January 06, 2022--Quidel Corporation (NASDAQ: QDEL) ("Quidel"), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it expects total revenues in the fourth quarter of 2021 to be in the range of $633 million to $637 million and full year total revenues to be in the range of $1,695 million to $1,699 million. COVID-19 revenues in the fourth quarter of 2021 are expected to be approximately $510 million.

Yahoo | January 6, 2022

Ortho-Clinical Diagnostics SA -- Moody's places Ortho-Clinical Diagnostics ratings under review for upgrade on proposed acquisition by Quidel

Rating Action: Moody's places Ortho-Clinical Diagnostics ratings under review for upgrade on proposed acquisition by QuidelGlobal Credit Research - 06 Jan 2022New York, January 06, 2022 -- Moody's Investors Service, ("Moody's") placed the ratings of Ortho-Clinical Diagnostics SA ("Ortho") on review for upgrade following an announcement by Quidel Corporation ("Quidel", not rated), that it has entered into a definitive agreement to acquire Ortho. The ratings placed under review for upgrade include the B1 Corporate Family Rating, B1-PD Probability of Default Rating (PDR), the Ba3 rating on existing senior secured bank credit facilities, and the B3 senior unsecured notes.

Yahoo | January 6, 2022

4 Stocks to Watch Out For as MedTech Rides on Buyout Frenzy

Here are some MedTech stocks - Quidel (QDEL), Thermo Fisher (TMO), Baxter (BAX) and BD (BDX) - that have been quite active in the acquisition front and therefore worth investor attention.

Yahoo | January 6, 2022

Quidel (QDEL) Gains As Market Dips: What You Should Know

Quidel (QDEL) closed the most recent trading day at $126.80, moving +0.51% from the previous trading session.

Yahoo | January 5, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6115 seconds.